Furthermore, kaempferol amplified the effect of cisplatin by down-regulating ABCC6 and cMyc expression, while up-regulating CDKN1A expression to advance apoptosis in OVCAR-3 human ovarian cancer cells. Here, MYC is linked to ovarian carcinoma.